CBFα3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6751-6760

  Shi, Meng Jiao ^a   Stavnezer, Janet ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; TRANSFORMING GROWTH FACTOR BETA1; CORE BINDING FACTOR; DNA BINDING PROTEIN; IMMUNOGLOBULIN A; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING SITE; GENE EXPRESSION REGULATION; GENE MUTATION; LYMPHOCYTE PROLIFERATION; LYMPHOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; ANIMAL; B CELL LYMPHOMA; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE REARRANGEMENT; GENETICS; IMMUNOGLOBULIN GENE; IMMUNOLOGY; MACROMOLECULE; PATHOLOGY; PHYSIOLOGY; REPORTER GENE; SPLEEN;

ANIMALS; B-LYMPHOCYTES; CORE BINDING FACTORS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, IMMUNOGLOBULIN; GENES, REPORTER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN M; LYMPHOMA, B-CELL; MACROMOLECULAR SUBSTANCES; MICE; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, B-CELL; SPLEEN; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032534230     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79.
2. Jung, S., K. Rajewsky, and A. Radbruch. 1993. Shutdown of class switch recombination by deletion of a switch region control element. Science 259:984.
3. Zhang, J., A. Bottaro, S. Li, V. Stewart, and F. W. Alt. 1993. A selective defect in IgG2b switching as a result of targeted mutation of the Iγ2b promoter and exon. EMBO J. 12:3529.
4. Bottaro, A., R. Lansford, L. Xu, J. Zhang, P. Rothman, and F. Alt. 1994. S region transcription (per se) promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J. 13:665.
5. Lorenz, M., S. Jung, and A. Radbruch. 1995. Switch transcripts in immunoglobulin class switching. Science 267:1825.
6. Lebman, D. A., F. D. Lee, and R. L. Coffman. 1990. Mechanism for transforming growth factor β and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J. Immunol. 144:952.
7. Lebman, D. A., D. Y. Nomura, R. L. Coffman, and F. D. Lee. 1990. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type β-induced isotype switching. Proc. Natl. Acad. Sci. USA 87:3962.
8. Shockett, P., and J. Stavnezer. 1991. Effect of cytokines on switching to IgA and a germline transcripts in the B lymphoma 1.29μ: transforming growth factor-β activates transcription of the unrearranged Cα gene. J. Immunol. 147:4374.
9. Gaff, C., R. J. Grumont, and S. Gerondakis. 1992. Transcriptional regulation of the germline immunoglobulin Cα and C∈ genes: implications tor commitment to an isotype switch. Int. Immunol. 4:1145.
10. Lin, Y.-C. A., and J. Stavnezer. 1992. Regulation of transcription of the germline Igα constant region gene by an ATF element and by novel transforming growth factor-β1-responsive elements. J. Immunol. 149:2914.
11. Nilsson, L., and S. Paschalis. 1993. The human Iα1 and Iα2 germline promoter elements: proximal positive and distal negative elements may regulate the tissue specific expression of Cα1 and Cα2 germline transcripts. Int. Immunol. 5:271.
12. Nilsson, L., P. Grant, I. Larsson, S. Pettersson, and P. Sideras. 1995. The human Iα1 region contains a TGF-β1 responsive enhancer and a putative recombination hotspot. Int. Immunol. 7:1191.
13. Speck, N. A., and S. Terryl. 1995. A new transcription factor family associated with human leukemias. Crit. Rev. Eukaryot. Gene Expr. 5:337.
14. Meyers, S., and S. W. Hiebert. 1995. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Crit. Rev. Eukaryot. Gene Expr. 5:365.
15. Meyers, S., J. R. Downing, and S. W. Hiebert. 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13:6336.
16. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90:6859.
17. Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, M. Naito-Fujimoto, Y. Ito, and K. Shigesada. 1993. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194:314.
18. Wang, S., Q. Wang, B. E. Rute, I. N. Melnikova, S. R. Keller, and N. A. Speck. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:3324.
19. Bae, S. C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and Y. Ito. 1994. PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 14:3242.
20. Bae, S. C., E. Takahashi, Y. W. Zhang, E. Ogawa, K. Shigesada, Y. Namba, M. Satake, and Y. Ito. 1995. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian runt domain. Gene 159:245.
21. Erman, B., M. Cortes, B. Nikolajczyk, N. Speck, and R. Sen. 1998. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol. Cell. Biol. 18:1322.
22. Merriman, H. L., A. J. v. Wijnen, S. Hiebert, J. P. Bidwell, E. Fey, J. Lian, J. Stein, and G. S. Stein. 1995. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 34:13125.
23. Banerjee, C., S. W. Hiebert, J. L. Stein, J. B. Lian, and G. S. Stein. 1996. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc. Natl. Acad. Sci. USA 93:4968.
24. Zaiman, A. L., A. F. Lewis, B. E. Crute, N. A. Speck, and J. Lenz. 1995. Transcriptional activity of core-binding factor α (AML1) and β subunits on murine leukemia virus enhancer cores. J. Virol. 68:2898.
25. Meyers, S., N. Lenny, and S. W. Hiebert. 1995. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15: 1974.
26. Meyers, S., N. Lenny, W. Sun, and S. W. Hiebert. 1996. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13:303.
27. Banerjee, C., L. R. McCabe, J.-Y. Choi, S. W. Hiebert, J. L. Stein, G. S. Stein, and J. B. Lian. 1997. Runt homology domain protein in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem. 66:1.
28. Satake, M., S. Nomura, Y. Yamaguchi-Iwai, Y. Takahama, Y. Hashimoto, M. Niki, Y. Kitamura, and Y. Ito. 1995. Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development. Mol. Cell. Biol. 15:1662.
29. Ducy, P., R. Zhang, V. Geoffroy, A. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747.
30. Bae, S. C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809.
31. Levanon, D., V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425.
32. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y. H. Gao, M. Inada, et al. 1997. Targeted disruption of Cbfα1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755.
33. Okuda, T., J. van Deursen, S. W. Hiebert, G. Grosveld, and J. R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321.
34. Wang, Q., T. Stacy, M. Binder, M. Marin-Padilla, A. H. Sharpe, and N. A. Speck. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93:3444.
35. Sasaki, K., H. Yagi, R. T. Bronson, K. Tominaga, T. Matsunashi, K. Deguchi, Y. Tani, T. Kishimoto, and T. Komori. 1996. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor β. Proc. Natl. Acad Sci. USA 93:12359.
36. Niki, M., H. Okada, H. Takano, J. Kuno, K. Tani, H. Hibino, S. Asano, Y. Ito, M. Satake, and T. Noda. 1997. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA 94:5697.
37. Wang, Q., T. Stacy, J. D. Miller, A. F. Lewis, T. L. Gu, X. Huang, J. H. Bushweller, J. C. Bories, F. W. Alt, G. Ryan, et al. 1996. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87:697.
38. Miyoshi, H., K. Shimizu, T. Kozu, N. Maseki, Y. Kaneko, and M. Ohki. 1991. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88:10431.
39. Stavnezer, J., S. Sirlin, and J. Abbott. 1985. Induction of immunoglobulin isotype switching in cultured I. 29 μ B lymphoma cells: characterization of the accompanying rearrangements of heavy chain genes. J. Exp. Med. 161:577.
40. + clones may be induced by lipopolysaccharide to both IgM secretion and isotype switching. Eur. J. Immunol. 17:555.
41. Kunimoto, D. Y., G. R. Harriman, and W. Strober. 1988. Regulation of IgA differentiation in CH12LX cells by lymphokines: IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA. J. Immunol. 141:713.
42. Wakatsuki, Y., and W. Strober. 1993. Effect of downregulation of germline transcripts on immunoglobulin A isotype differentiation. J. Exp. Med. 178:129.
43. Kim, K., C. Kanellopoulous-Langevin, R. Merwin, D. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549.
44. Xu, M., and J. Stavnezer. 1992. Regulation of transcription of immunoglobulin germ-line γ1 RNA: analysis of the promoter/enhancer. EMBO J. 11:145.
45. Ho, N. S., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51.
46. Nordeen, S. K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454.
47. Wijmenga, C., N. A. Speck, N. C. Dracopoli, M. H. Hofker, P. Liu, and F. S. Collins. 1995. Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter. Genomics 26:611.
48. Bae, S. C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809.
49. Lin, S.-C., and J. Stavnezer. 1996. Activation of NF-κB/Rel by CD40 engagement induces the mouse germline immunoglobulin Cγ1 promoter. Mol. Cell. Biol. 16:4591.
50. Miner, J. N., and K. R. Yamamoyo. 1992. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev. 6:2491.
51. Qiu, G., and J. Stavnezer. 1998. Over-expression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I.29μ B cell line. J. Immunol. 161:2906.
52. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:6419.
53. Sun, W., B. J. Graves, and N. A. Speck. 1995. Transactivation of the Moloney murine leukemia virus and T-cell receptor β-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69:4941.
54. Rossi, P., A. B. Roberts, N. S. Roche, G. Karsenty, M. B. Sporn, and B. de Crombrugghe. 1988. A nuclear factor I binding site mediates the transcriptional activation of a type I collagen promoter by TGFβ. Cell 52:405.
55. Keeton, M. R., S. A. Curriden, A.-J. v. Zonneveld, and D. J. Loskutoff. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to TGFβ. J. Biol. Chem. 266:23048.
56. Riccio, A., P. V. Pedone, L. R. Lund, T. Olesen, H. S. Olson, and P. A. Andreasen. 1992. TGFβ1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-NF-I in the type I plasminogen activator inhibitor gene. Mol. Cell. Biol. 12:1846.
57. Kim, S.-J., P. Angel, R. Lafyatis, K. Hattori, K. Y. Kim, M. B. Sporn, M. Karin, and A. B. Roberts. 1990. Autoinduction of transforming growth factor β1 is mediated by the AP1 complex. Mol. Cell. Biol. 10:1492.
58. Chung, K., A. Agarwal, J. Uitto, and A. Mauviel. 1996. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 271:3272.
59. Mauviel, A., K. Chung, A. Agarwal, K. Tamai, and J. Uitto. 1996. Cell-specific induction of distinct oncogenes of the Jun family is responsive for different regulation of collagenase gene expression by transforming growth factor-β in fibroblasts and keratinocytes. J. Biol. Chem. 271:10917.
60. INK4B through a Sp1 consensus site. J. Biol. Chem. 270:26750.
61. Zeng, C., S. McNeil, S. Pockwinse, J. Nickerson, L. Shopland, J. B. Lawrence, S. Penman, S. Hiebert, J. B. Lian, A. J. v. Wijnen, et al. 1998. Intranuclear targeting of AML/CBFα regulatory factors to nuclear matrix-associated transcriptional domains. Proc. Natl. Acad. Sci. USA 95:1585.
62. Furukawa, K., Y. Yamaguchi, E. Ogawa, K. Shigesada, M. Satake, and Y. Ito. 1990. A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors. Cell Growth Differ. 1:135.
63. Zhu, X., J. E. Yeadon, and S. J. Burden. 1994. AML1 is expressed in skeletal muscle and is regulated by innervation. Mol. Cell. Biol. 14:8051.
64. Weinstein, P. D., and J. J. Cebra. 1991. The preference for switching to IgA expression by Peyer's patch germinal center B cells is likely due to the intrinsic influence of their microenvironment. J. Immunol. 147:4126.
65. Wotton, D., J. Ghysdael, S. Wang, N. A. Speck, and M. J. Owen. 1994. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell. Biol. 14:840.
66. Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995.
67. Massague, J., A. Hata, and F. Liu. 1997. TGF-β signalling through the Smad pathway. Trends Cell Biol. 7:187.
68. Heldin, C. H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465.
69. Zawel, L., J. L. Dai, P. Buckhaults, S. Zhou, K. W. Kinzler, B. Vogelstein, and S. E. Kern. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611.